| NCT ID | NCT06284421 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Chicago |
| Condition | Uterine Tone Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-02-08 |
| Primary Completion | 2026-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-02-08 with a primary completion date of 2026-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will evaluate the use of a durometer to measure uterine tone in parturients undergoing cesarean delivery.
Eligibility Criteria
Inclusion Criteria: * Non-emergent (scheduled) cesarean delivery at University of Chicago Family Birth Center * Patients ages 18-50 Exclusion Criteria: * Patients undergoing unscheduled (intrapartum) cesarean delivery * Ages \<18 or \>50 years old * Intrapartum cesarean hysterectomy * Inability to provide independent, informed consent due to impairment or intellectual disability * Non-English speaking patients
Contact & Investigator
Naida Cole, MD
PRINCIPAL INVESTIGATOR
University of Chicago
Frequently Asked Questions
Who can join the NCT06284421 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Uterine Tone Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06284421 currently recruiting?
Yes, NCT06284421 is actively recruiting participants. Contact the research team at amcauley1@dacc.uchicago.edu for enrollment information.
Where is the NCT06284421 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT06284421 clinical trial?
NCT06284421 is sponsored by University of Chicago. The principal investigator is Naida Cole, MD at University of Chicago. The trial plans to enroll 20 participants.